ACT-HIB 10 micrograms/0.5 ml, powder and solvent for solution for injection in a pre-filled syringe. Haemophilus type b conjugate vaccine bottle, 0.5 ml
Active ingredients: HAEMOPHILUS TYPE B (POLYOSIDE) CONJUGUÉ À LA PROTÉINE TÉTANIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottle, 0.5 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACT-HIB 10 microgrammes/0,5 mL, poudre et solvant pour solution injectable en seringue préremplie. Vaccin conjugué de l'Haemophilus type b
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 0,5 mL
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1992
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61104024CIP73347201CIP133400933472016Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HAEMOPHILUS TYPE B (POLYOSIDE) CONJUGUÉ À LA PROTÉINE TÉTANIQUEpoudre | 10 microgrammes · une dose de 0,5 mL de vaccin reconstitué | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.